Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06225479 · ClinicalTrials.gov registry record · NA

PRescription Exercise for Older Men With Urinary Disease

A NA study of Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms, sponsored by University of California, San Francisco.

Recruiting
Registry status
NA
Development phase
68
Enrollment target
2
Study locations

NCT06225479 is a NA study of Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 68 participants, below the 550-participant average among 29 other Benign Prostatic Hyperplasia trials with a reported enrollment target (88% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06225479, a NA study of Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms, is actively recruiting participants, sponsored by University of California, San Francisco.

RECRUITING
Registry status
NA
Development phase
68 participants
Enrollment target
2
Study locations

Study Summary

This is a single-center pilot randomized controlled trial among 68 physically "inactive" older men with lower urinary tract symptoms (LUTS) attributed to benign prostatic hyperplasia (LUTS/BPH) assessing a 12-week remote exercise intervention versus health education control.

Interventions

  • BEHAVIORAL Exercise
  • OTHER Calls and Newsletter

Study Locations (2)

California

  • San Francisco VA Medical Center - San Francisco
  • UCSF Health - Mission Bay Campus - San Francisco

Trial Details

FieldValue
Enrollment Target 68 participants
Start Date 2024-01-03
Est. Completion 2026-04-01
Phase NA

What the Registry Record Tells You About NCT06225479

The ClinicalTrials.gov registry entry for NCT06225479 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 550-participant average among 29 other Benign Prostatic Hyperplasia trials with a reported enrollment target (88% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Benign Prostatic Hyperplasia appearing as the primary indexed condition, and to 2 interventions - of which Exercise is the first listed.

NCT06225479 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06225479 about?

NCT06225479 is a clinical study titled "PRescription Exercise for Older Men With Urinary Disease". This is a single-center pilot randomized controlled trial among 68 physically "inactive" older men with lower urinary tract symptoms (LUTS) attributed to benign prostatic hyperplasia (LUTS/BPH) assessing a 12-week remote exercise intervention versus health education control.

What is the current status of trial NCT06225479?

This trial is currently recruiting. It is a NA study. The enrollment target is 68 participants. The study started on 2024-01-03. Estimated completion is 2026-04-01.

What conditions does trial NCT06225479 study?

This clinical trial studies the following conditions: Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms.

What interventions are being tested in trial NCT06225479?

The interventions under investigation include: Exercise (BEHAVIORAL), Calls and Newsletter (OTHER).

Who is sponsoring clinical trial NCT06225479?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06225479 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Benign Prostatic Hyperplasia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.